CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease

CAR–T cell therapy for non-Hodgkin lymphoma appeared as safe and effective in patients with rheumatic autoimmune disease as in those without and also improved control of the underlying autoimmunity.

Related Keywords

Ohio ,United States ,Cleveland ,Jiasheng Wang ,University Hospitals Cleveland Medical Center , ,Bone Marrow ,Non Hodgkin Amp 039s Lymphoma ,Non Hodgkin Lymphoma ,Hl ,Chimeric Antigen Receptort Cell Therapy ,Chimeric Antigen Receptors ,Himeric Immunoreceptors ,Himerict Cell Receptors ,Rtificialt Cell Receptors ,Art Chimaeric Antigen Receptort Cell Therapy Receptors Immunoreceptors Chimaerict ,Biologic Therapy ,Iologics ,Autoimmune Disease ,